Go Pro

Trading of Modular Medical was halted at 09:55 AM EST due to "LULD Pause".

Modular Medical (MODD) Competitors

Modular Medical logo
$4.88 -0.06 (-1.21%)
Closing price 04:00 PM Eastern
Extended Trading
$4.56 -0.32 (-6.56%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MODD vs. SNWV, LNSR, AGPU, IINN, and DXR

Should you buy Modular Medical stock or one of its competitors? MarketBeat compares Modular Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Modular Medical include Sanuwave Health (SNWV), LENSAR (LNSR), Predictive Oncology (AGPU), Inspira Technologies OXY B.H.N. (IINN), and Daxor (DXR). These companies are all part of the "medical equipment" industry.

How does Modular Medical compare to Sanuwave Health?

Modular Medical (NASDAQ:MODD) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 417.77%. Given Sanuwave Health's stronger consensus rating and higher probable upside, analysts clearly believe Sanuwave Health is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sanuwave Health
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Sanuwave Health has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
Sanuwave Health$44.05M1.92$11.81M$0.3329.85

In the previous week, Modular Medical had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 4 mentions for Modular Medical and 2 mentions for Sanuwave Health. Sanuwave Health's average media sentiment score of 0.93 beat Modular Medical's score of 0.31 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Modular Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sanuwave Health
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Modular Medical has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Sanuwave Health has a net margin of 35.96% compared to Modular Medical's net margin of 0.00%. Modular Medical's return on equity of -245.85% beat Sanuwave Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
Sanuwave Health 35.96%-450.56%44.87%

Summary

Sanuwave Health beats Modular Medical on 14 of the 16 factors compared between the two stocks.

How does Modular Medical compare to LENSAR?

Modular Medical (NASDAQ:MODD) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Modular Medical has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
LENSAR$57.70M1.22-$34.28M-$0.58N/A

In the previous week, Modular Medical had 3 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for Modular Medical and 1 mentions for LENSAR. LENSAR's average media sentiment score of 1.89 beat Modular Medical's score of 0.31 indicating that LENSAR is being referred to more favorably in the news media.

Company Overall Sentiment
Modular Medical Neutral
LENSAR Very Positive

LENSAR has a net margin of 50.94% compared to Modular Medical's net margin of 0.00%. LENSAR's return on equity of -183.19% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
LENSAR 50.94%-183.19%42.26%

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by insiders. Comparatively, 65.8% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LENSAR has a consensus price target of $10.00, suggesting a potential upside of 74.83%. Given LENSAR's stronger consensus rating and higher possible upside, analysts clearly believe LENSAR is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Modular Medical has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Summary

LENSAR beats Modular Medical on 12 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Predictive Oncology?

Modular Medical (NASDAQ:MODD) and Predictive Oncology (NASDAQ:AGPU) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Modular Medical has higher earnings, but lower revenue than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
Predictive Oncology$120K679.86-$233.10M-$8.18N/A

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are held by institutional investors. 7.1% of Modular Medical shares are held by insiders. Comparatively, 1.2% of Predictive Oncology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Modular Medical had 2 more articles in the media than Predictive Oncology. MarketBeat recorded 4 mentions for Modular Medical and 2 mentions for Predictive Oncology. Predictive Oncology's average media sentiment score of 0.93 beat Modular Medical's score of 0.31 indicating that Predictive Oncology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Modular Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Predictive Oncology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Modular Medical has a net margin of 0.00% compared to Predictive Oncology's net margin of -470,383.31%. Modular Medical's return on equity of -245.85% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
Predictive Oncology -470,383.31%-7,363.67%-626.32%

Modular Medical has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Predictive Oncology has a beta of 3.47, meaning that its share price is 247% more volatile than the broader market.

Summary

Modular Medical beats Predictive Oncology on 8 of the 12 factors compared between the two stocks.

How does Modular Medical compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

In the previous week, Modular Medical had 4 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 4 mentions for Modular Medical and 0 mentions for Inspira Technologies OXY B.H.N.. Modular Medical's average media sentiment score of 0.31 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
Modular Medical Neutral

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Modular Medical N/A -245.85%-190.80%

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Modular Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K200.27-$13.22MN/AN/A
Modular MedicalN/AN/A-$18.82M-$14.71N/A

Summary

Inspira Technologies OXY B.H.N. beats Modular Medical on 6 of the 9 factors compared between the two stocks.

How does Modular Medical compare to Daxor?

Modular Medical (NASDAQ:MODD) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
DaxorN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Daxor
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Daxor had 1 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Daxor and 4 mentions for Modular Medical. Daxor's average media sentiment score of 0.57 beat Modular Medical's score of 0.31 indicating that Daxor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Modular Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Daxor
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Modular Medical has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market. Comparatively, Daxor has a beta of 0.27, indicating that its stock price is 73% less volatile than the broader market.

Daxor's return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
Daxor N/A N/A N/A

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Comparatively, 51.5% of Daxor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Daxor beats Modular Medical on 7 of the 9 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MODD vs. The Competition

MetricModular MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$23.03M$8.70B$6.85B$12.20B
Dividend YieldN/A2.47%2.66%6.22%
P/E Ratio-0.3316.2626.0424.36
Price / SalesN/A7.81550.17103.06
Price / CashN/A18.0729.0936.93
Price / Book0.393.4610.986.49
Net Income-$18.82M$226.25M$3.57B$336.61M
7 Day Performance12.44%2.48%3.06%0.90%
1 Month Performance-2.01%-2.95%0.72%-0.36%
1 Year Performance-76.04%1.11%36.82%31.26%

Modular Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MODD
Modular Medical
0.8837 of 5 stars
$4.88
-1.2%
N/A-75.7%$23.03MN/AN/A20
SNWV
Sanuwave Health
2.125 of 5 stars
$8.56
+4.4%
$51.00
+495.8%
-71.3%$73.61M$44.34M25.9440
LNSR
LENSAR
2.9428 of 5 stars
$6.06
+5.9%
$10.00
+65.0%
-55.7%$73.35M$57.70MN/A110
AGPU
Predictive Oncology
0.5851 of 5 stars
$6.47
-1.8%
N/AN/A$70.01M$120KN/A30
IINN
Inspira Technologies OXY B.H.N.
0.4997 of 5 stars
$1.90
-5.5%
N/A+89.4%$68.30M$289KN/A20

Related Companies and Tools


This page (NASDAQ:MODD) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners